Management of Sickle Cell Disease: A Review for Physician Education in Nigeria (Sub-Saharan Africa)

被引：78

作者：

Adewoyin, Ademola Samson ^{[1
]}

机构：

[1] Univ Benin Teaching Hosp, Dept Haematol & Blood Transfus, PMB 1111, Benin, Edo State, Nigeria

来源：

ANEMIA | 2015年 / 2015卷

关键词：

D O I：

10.1155/2015/791498

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sickle cell disease (SCD) predominates in sub-Saharan Africa, East Mediterranean areas, Middle East, and India. Nigeria, being the most populous black nation in the world, bears its greatest burden in sub-Saharan Africa. The last few decades have witnessed remarkable scientific progress in the understanding of the complex pathophysiology of the disease. Improved clinical insights have heralded development and establishment of disease modifying interventions such as chronic blood transfusions, hydroxyurea therapy, and haemopoietic stem cell transplantation. Coupled with parallel improvements in general supportive, symptomatic, and preventive measures, current evidence reveals remarkable appreciation in quality of life among affected individuals in developed nations. Currently, in Nigeria and other West African states, treatment and control of SCD are largely suboptimal. Improved knowledge regarding SCD phenotypes and its comprehensive care among Nigerian physicians will enhance quality of care for affected persons. This paper therefore provides a review on the aetiopathogenesis, clinical manifestations, and management of SCD in Nigeria, with a focus on its local patterns and peculiarities. Established treatment guidelines as appropriate in the Nigerian setting are proffered, as well as recommendations for improving care of affected persons.

引用

页数：21

共 190 条

[1]

Modell B., Guidelines for the Control of Haemoglobin Disorders, (1989)

[2]

Serjeant G.R., Sickle-cell disease, The Lancet, 350, 9079, pp. 725-730, (1997)

[3]

Modell B., Darlison M., Global Epidemiology of Haemoglobin Disorders and Derived Service Indicators, 86, 6, pp. 480-487, (2008)

[4]

Management of haemoglobin disorders, Proceedings of the Report of Joint WHO-TIF Meeting, (2007)

[5]

Piel F.B., Patil A.P., Howes R.E., Et al., Global epidemiology of Sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates, The Lancet, 381, 9861, pp. 142-151, (2013)

[6]

Sickle Cell Disease Prevention and Control, (2013)

[7]

Serjeant G.R., Serjeant B.E., The epidemiology of sickle cell disorder: A challenge for Africa, Archives of Ibadan Medicine, 2, 2, pp. 46-52, (2001)

[8]

Okwi A.L., Byarugaba W., Ndugwa C.M., Parkes A., Ocaido M., Tumwine J.K., An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda, BMC Blood Disorders, 10, (2010)

[9]

Fleming A.F., Storey J., Molineaux L., Iroko E.A., Attai E.D., Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival, Annals of Tropical Medicine and Parasitology, 73, 2, pp. 161-172, (1979)

[10]

Uzoegwu P.N., Onwurah A.E., Prevalence of haemoglobinopathy and malaria diseases in the population of old Aguata Division, Anambra State, Nigeria, Biokemistri, 15, 2, pp. 57-66, (2003)

← 1 2 3 4 5 6 7 8 9 10 →